BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36562288)

  • 1. Mistletoe lectin inhibits growth of Myc-amplified small-cell lung cancer.
    Shatat MA; Gauthier B; Yoon S; Yuan E; Yang P; Narla G; Dowlati A; Lee RT
    Cancer Med; 2023 Apr; 12(7):8378-8387. PubMed ID: 36562288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family matters: How MYC family oncogenes impact small cell lung cancer.
    Brägelmann J; Böhm S; Guthrie MR; Mollaoglu G; Oliver TG; Sos ML
    Cell Cycle; 2017 Aug; 16(16):1489-1498. PubMed ID: 28737478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNAs as Potential Targets in Small Cell Lung Cancer: MYC -dependent Regulation.
    Tokgun O; Tokgun PE; Inci K; Akca H
    Anticancer Agents Med Chem; 2020; 20(17):2074-2081. PubMed ID: 32698750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation.
    Fiorentino FP; Tokgün E; Solé-Sánchez S; Giampaolo S; Tokgün O; Jauset T; Kohno T; Perucho M; Soucek L; Yokota J
    Oncotarget; 2016 May; 7(21):31014-28. PubMed ID: 27105536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion.
    Chalishazar MD; Wait SJ; Huang F; Ireland AS; Mukhopadhyay A; Lee Y; Schuman SS; Guthrie MR; Berrett KC; Vahrenkamp JM; Hu Z; Kudla M; Modzelewska K; Wang G; Ingolia NT; Gertz J; Lum DH; Cosulich SC; Bomalaski JS; DeBerardinis RJ; Oliver TG
    Clin Cancer Res; 2019 Aug; 25(16):5107-5121. PubMed ID: 31164374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYCL1 Amplification and Expression of L-Myc and c-Myc in Surgically Resected Small-Cell Lung Carcinoma.
    Qin J; Xie F; Li C; Han N; Lu H
    Pathol Oncol Res; 2021; 27():1609775. PubMed ID: 34257619
    [No Abstract]   [Full Text] [Related]  

  • 7. MYCL is a target of a BET bromodomain inhibitor, JQ1, on growth suppression efficacy in small cell lung cancer cells.
    Kato F; Fiorentino FP; Alibés A; Perucho M; Sánchez-Céspedes M; Kohno T; Yokota J
    Oncotarget; 2016 Nov; 7(47):77378-77388. PubMed ID: 27764802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human small-cell lung cancers show amplification and expression of the N-myc gene.
    Nau MM; Brooks BJ; Carney DN; Gazdar AF; Battey JF; Sausville EA; Minna JD
    Proc Natl Acad Sci U S A; 1986 Feb; 83(4):1092-6. PubMed ID: 2869482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the activation of the myc family oncogene and of its stability over time in xenografted human lung carcinomas.
    Gazzeri S; Brambilla E; Chauvin C; Jacrot M; Benabid AL; Brambilla C
    Cancer Res; 1990 Mar; 50(5):1566-70. PubMed ID: 2154327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735.
    Hook KE; Garza SJ; Lira ME; Ching KA; Lee NV; Cao J; Yuan J; Ye J; Ozeck M; Shi ST; Zheng X; Rejto PA; Kan JL; Christensen JG; Pavlicek A
    Mol Cancer Ther; 2012 Mar; 11(3):710-9. PubMed ID: 22222631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYC drives platinum resistant SCLC that is overcome by the dual PI3K-HDAC inhibitor fimepinostat.
    Chen J; Guanizo AC; Jakasekara WSN; Inampudi C; Luong Q; Garama DJ; Alamgeer M; Thakur N; DeVeer M; Ganju V; Watkins DN; Cain JE; Gough DJ
    J Exp Clin Cancer Res; 2023 Apr; 42(1):100. PubMed ID: 37098540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer.
    Nau MM; Brooks BJ; Battey J; Sausville E; Gazdar AF; Kirsch IR; McBride OW; Bertness V; Hollis GF; Minna JD
    Nature; 1985 Nov 7-13; 318(6041):69-73. PubMed ID: 2997622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic requirement for Mycl and efficacy of RNA Pol I inhibition in mouse models of small cell lung cancer.
    Kim DW; Wu N; Kim YC; Cheng PF; Basom R; Kim D; Dunn CT; Lee AY; Kim K; Lee CS; Singh A; Gazdar AF; Harris CR; Eisenman RN; Park KS; MacPherson D
    Genes Dev; 2016 Jun; 30(11):1289-99. PubMed ID: 27298335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myc manipulates the miRNA content and biologic functions of small cell lung cancer cell-derived small extracellular vesicles.
    Tokgün O; İnci K
    Mol Biol Rep; 2022 Aug; 49(8):7953-7965. PubMed ID: 35690961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromodomain and hedgehog pathway targets in small cell lung cancer.
    Kaur G; Reinhart RA; Monks A; Evans D; Morris J; Polley E; Teicher BA
    Cancer Lett; 2016 Feb; 371(2):225-39. PubMed ID: 26683772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics.
    Takahashi T; Obata Y; Sekido Y; Hida T; Ueda R; Watanabe H; Ariyoshi Y; Sugiura T; Takahashi T
    Cancer Res; 1989 May; 49(10):2683-8. PubMed ID: 2540905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYC paralog-dependent apoptotic priming orchestrates a spectrum of vulnerabilities in small cell lung cancer.
    Dammert MA; Brägelmann J; Olsen RR; Böhm S; Monhasery N; Whitney CP; Chalishazar MD; Tumbrink HL; Guthrie MR; Klein S; Ireland AS; Ryan J; Schmitt A; Marx A; Ozretić L; Castiglione R; Lorenz C; Jachimowicz RD; Wolf E; Thomas RK; Poirier JT; Büttner R; Sen T; Byers LA; Reinhardt HC; Letai A; Oliver TG; Sos ML
    Nat Commun; 2019 Aug; 10(1):3485. PubMed ID: 31375684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate.
    Ireland AS; Micinski AM; Kastner DW; Guo B; Wait SJ; Spainhower KB; Conley CC; Chen OS; Guthrie MR; Soltero D; Qiao Y; Huang X; Tarapcsák S; Devarakonda S; Chalishazar MD; Gertz J; Moser JC; Marth G; Puri S; Witt BL; Spike BT; Oliver TG
    Cancer Cell; 2020 Jul; 38(1):60-78.e12. PubMed ID: 32473656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression.
    Barr LF; Campbell SE; Diette GB; Gabrielson EW; Kim S; Shim H; Dang CV
    Cancer Res; 2000 Jan; 60(1):143-9. PubMed ID: 10646866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
    Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
    Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.